Why is Medplus Health falling/rising?

As of 01-Oct, Medplus Health Services Ltd is experiencing a decline in its stock price, currently at Rs 742.75, which reflects a decrease of Rs 14.0 or 1.85%. The stock has underperformed its sector by 1.61% today and has been on a consecutive downward trend for the last four days, resulting in a total decline of 7.08% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite showing healthy long-term growth with a significant annual increase in operating profit and positive results over the last four quarters, the stock's performance has been negatively impacted by poor management efficiency, as indicated by a low average Return on Capital Employed (ROCE) of 6.44% and a weak EBIT to Interest ratio of 1.61. Furthermore, the high percentage of pledged promoter shares (59.34%) adds downward pressure in a falling market.
In the broader market context, Medplus Health's short-term performance has been notably weak, with a 1-week return of -5.96%, compared to a slight decline of only 0.90% in the Sensex. Over the past month, the stock has decreased by 11.79%, while the benchmark has gained 0.77%. This stark contrast highlights the stock's struggles relative to the market. Although it has generated a positive return of 11.94% over the past year, the overall negative sentiment and recent performance trends suggest that investors are cautious, particularly given the company's challenges in managing debt and profitability.